These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28170539)
1. Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis. Javed A; Aslam T; Jones SA; Ashworth J Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):954-958. PubMed ID: 28170539 [TBL] [Abstract][Full Text] [Related]
2. Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis. McGrath O; Sornalingam K; Aslam T; Ashworth J Cornea; 2023 Aug; 42(8):992-999. PubMed ID: 36857777 [TBL] [Abstract][Full Text] [Related]
3. Variability in the ocular phenotype in mucopolysaccharidosis. Sornalingam K; Javed A; Aslam T; Sergouniotis P; Jones S; Ghosh A; Ashworth J Br J Ophthalmol; 2019 Apr; 103(4):504-510. PubMed ID: 30120129 [TBL] [Abstract][Full Text] [Related]
4. Use of iris recognition camera technology for the quantification of corneal opacification in mucopolysaccharidoses. Aslam TM; Shakir S; Wong J; Au L; Ashworth J Br J Ophthalmol; 2012 Dec; 96(12):1466-8. PubMed ID: 22394489 [TBL] [Abstract][Full Text] [Related]
5. Measuring corneal clouding in patients suffering from mucopolysaccharidosis with the Pentacam densitometry programme. Elflein HM; Hofherr T; Berisha-Ramadani F; Weyer V; Lampe C; Beck M; Pitz S Br J Ophthalmol; 2013 Jul; 97(7):829-33. PubMed ID: 23685998 [TBL] [Abstract][Full Text] [Related]
6. Corneal hysteresis in mucopolysaccharidosis I and VI. Fahnehjelm KT; Chen E; Winiarski J Acta Ophthalmol; 2012 Aug; 90(5):445-8. PubMed ID: 21232085 [TBL] [Abstract][Full Text] [Related]
7. Therapy for the mucopolysaccharidoses. Valayannopoulos V; Wijburg FA Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v49-59. PubMed ID: 22210671 [TBL] [Abstract][Full Text] [Related]
9. Findings in the anterior segment on ultrasound biomicroscopy in Maroteaux-Lamy syndrome. Casanova FH; Adan CB; Allemann N; de Freitas D Cornea; 2001 Apr; 20(3):333-8. PubMed ID: 11322427 [TBL] [Abstract][Full Text] [Related]
10. The ocular features of the mucopolysaccharidoses. Ashworth JL; Biswas S; Wraith E; Lloyd IC Eye (Lond); 2006 May; 20(5):553-63. PubMed ID: 15905869 [TBL] [Abstract][Full Text] [Related]
11. Clearing of cornea after perforating keratoplasty in mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). Naumann G N Engl J Med; 1985 Apr; 312(15):995. PubMed ID: 3919302 [No Abstract] [Full Text] [Related]
12. Further electroretinographic studies of patients with mucopolysaccharidoses. Leung LS; Weinstein GW; Hobson RR Birth Defects Orig Artic Ser; 1971 Mar; 7(3):32-40. PubMed ID: 5006141 [TBL] [Abstract][Full Text] [Related]
13. Influence of Corneal Opacity on Intraocular Pressure Assessment in Patients with Lysosomal Storage Diseases. Wasielica-Poslednik J; Politino G; Schmidtmann I; Lorenz K; Bell K; Pfeiffer N; Pitz S PLoS One; 2017; 12(1):e0168698. PubMed ID: 28081172 [TBL] [Abstract][Full Text] [Related]
14. Clinical ocular manifestations of Taiwanese patients with mucopolysaccharidoses VI (Maroteaux-Lamy syndrome). Lin HY; Huang YH; Lei SY; Chen LJ; Lin SP Taiwan J Ophthalmol; 2019; 9(3):194-197. PubMed ID: 31572657 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis. Ferrari S; Ponzin D; Ashworth JL; Fahnehjelm KT; Summers CG; Harmatz PR; Scarpa M Br J Ophthalmol; 2011 May; 95(5):613-9. PubMed ID: 20852315 [TBL] [Abstract][Full Text] [Related]